Comparison of Oxygen Interventions and Defibrillator Efficiency (CODE)
Atrial Fibrillation, Atrial Flutter
About this trial
This is an interventional treatment trial for Atrial Fibrillation focused on measuring Cardioversion, Cardiac Arrythmias, Myocardial Injury, Defibrillators, Biomarkers
Eligibility Criteria
Inclusion Criteria:
- Atrial fibrillation or -flutter
Exclusion Criteria:
- Patients <18 years of age
- Pregnancy
- Haemodynamically unstable patients
- Other arrhythmias
- Untreated hyperthyroidism
Sites / Locations
- Randers Regional Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Active Comparator
Active Comparator
Active Comparator
1 ("Standard": Oxygen / LIFEPAK 20)
2 (room air / LIFEPAK 20)
3 (Oxygen / Schiller Defigard 5000)
4 (Room air / Schiller Defigard 5000)
Intervention: Cardioversion with a biphasic truncated exponential waveform Intervention: Hyperoxia during cardioversion
Intervention: Cardioversion with a biphasic truncated exponential waveform Intervention: Normoxia during cardioversion
Intervention: Cardioversion with a pulsed biphasic waveform Intervention: Hyperoxia during cardioversion
Intervention: Cardioversion with a pulsed biphasic waveform Intervention: Normoxia during cardioversion